These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 27335030)
1. Identification of Novel Key Molecules Involved in Spatial Memory Impairment in Triple Transgenic Mice of Alzheimer's Disease. Ying M; Sui X; Zhang Y; Sun Q; Qu Z; Luo X; Chang RC; Ni J; Liu J; Yang X Mol Neurobiol; 2017 Jul; 54(5):3843-3858. PubMed ID: 27335030 [TBL] [Abstract][Full Text] [Related]
2. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis. Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456 [TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease. Sui X; Ren X; Huang P; Li S; Ma Q; Ying M; Ni J; Liu J; Yang X J Alzheimers Dis; 2014; 40(3):575-86. PubMed ID: 24496070 [TBL] [Abstract][Full Text] [Related]
4. Proteomic alterations of brain subcellular organelles caused by low-dose copper exposure: implication for Alzheimer's disease. Yu H; Wang D; Zou L; Zhang Z; Xu H; Zhu F; Ren X; Xu B; Yuan J; Liu J; Spencer PS; Yang X Arch Toxicol; 2018 Apr; 92(4):1363-1382. PubMed ID: 29383422 [TBL] [Abstract][Full Text] [Related]
5. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease. Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247 [TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg1 Ameliorates Behavioral Abnormalities and Modulates the Hippocampal Proteomic Change in Triple Transgenic Mice of Alzheimer's Disease. Nie L; Xia J; Li H; Zhang Z; Yang Y; Huang X; He Z; Liu J; Yang X Oxid Med Cell Longev; 2017; 2017():6473506. PubMed ID: 29204248 [TBL] [Abstract][Full Text] [Related]
7. Melatonin ameliorates anxiety and depression-like behaviors and modulates proteomic changes in triple transgenic mice of Alzheimer's disease. Nie L; Wei G; Peng S; Qu Z; Yang Y; Yang Q; Huang X; Liu J; Zhuang Z; Yang X Biofactors; 2017 Jul; 43(4):593-611. PubMed ID: 28608594 [TBL] [Abstract][Full Text] [Related]
8. Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice. Clark JK; Furgerson M; Crystal JD; Fechheimer M; Furukawa R; Wagner JJ Neurobiol Learn Mem; 2015 Nov; 125():152-162. PubMed ID: 26385257 [TBL] [Abstract][Full Text] [Related]
9. Spatial memory impairment by TRPC1 depletion is ameliorated by environmental enrichment. Xing R; Zhang Y; Xu H; Luo X; Chang RC; Liu J; Yang X Oncotarget; 2016 May; 7(19):27855-73. PubMed ID: 27034165 [TBL] [Abstract][Full Text] [Related]
10. Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease. Muthukumaran K; Kanwar A; Vegh C; Marginean A; Elliott A; Guilbeault N; Badour A; Sikorska M; Cohen J; Pandey S J Alzheimers Dis; 2018; 61(1):221-236. PubMed ID: 29154270 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Molecular Abnormalities Revealed by Proteomic Analysis of Hippocampal Organelles of Mice Triple Transgenic for Alzheimer Disease. Yu H; Lin X; Wang D; Zhang Z; Guo Y; Ren X; Xu B; Yuan J; Liu J; Spencer PS; Wang JZ; Yang X Front Mol Neurosci; 2018; 11():74. PubMed ID: 29593495 [TBL] [Abstract][Full Text] [Related]
12. Adiponectin Ameliorates Cognitive Behaviors and in vivo Synaptic Plasticity Impairments in 3xTg-AD Mice. Yan XD; Qu XS; Yin J; Qiao J; Zhang J; Qi JS; Wu MN J Alzheimers Dis; 2022; 85(1):343-357. PubMed ID: 34806605 [TBL] [Abstract][Full Text] [Related]
13. Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease. Syal C; Kosaraju J; Hamilton L; Aumont A; Chu A; Sarma SN; Thomas J; Seegobin M; Dilworth FJ; He L; Wondisford FE; Zimmermann R; Parent M; Fernandes K; Wang J Theranostics; 2020; 10(14):6337-6360. PubMed ID: 32483456 [No Abstract] [Full Text] [Related]
14. Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease. Shishido H; Kishimoto Y; Kawai N; Toyota Y; Ueno M; Kubota T; Kirino Y; Tamiya T Neurosci Lett; 2016 Aug; 629():62-67. PubMed ID: 27373531 [TBL] [Abstract][Full Text] [Related]
15. A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease. Li T; Jiao JJ; Hölscher C; Wu MN; Zhang J; Tong JQ; Dong XF; Qu XS; Cao Y; Cai HY; Su Q; Qi JS Hippocampus; 2018 May; 28(5):358-372. PubMed ID: 29473979 [TBL] [Abstract][Full Text] [Related]
16. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease. Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830 [TBL] [Abstract][Full Text] [Related]
17. Collapsin response mediator protein 5 (CRMP5) causes social deficits and accelerates memory loss in an animal model of Alzheimer's disease. Lin YS; Lin YF; Chen KC; Yang YK; Hsiao YH Neuropharmacology; 2019 Oct; 157():107673. PubMed ID: 31233825 [TBL] [Abstract][Full Text] [Related]
18. Age and sex differences in motivation and spatial working memory in 3xTg-AD mice in the Hebb-Williams maze. Fertan E; Wong AA; Vienneau NA; Brown RE Behav Brain Res; 2019 Sep; 370():111937. PubMed ID: 31121220 [TBL] [Abstract][Full Text] [Related]
19. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease. Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283 [TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms. Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]